Active Ingredient: CAPMATINIB HYDROCHLORIDE
Proprietary Name: TABRECTA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 200MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N213591
Product Number: 002
Approval Date: May 6, 2020
Applicant Holder Full Name: NOVARTIS PHARMACEUTICAL CORP
Marketing Status:
Prescription
Patent and Exclusivity Information
